NEW
YORK, Dec. 15, 2024 /PRNewswire/ -- The global
heart valve repair and replacement devices market size is
estimated to grow by USD 2.58 billion
from 2024 to 2028, according to Technavio. The market is estimated
to grow at a CAGR of 7.08% during the forecast period. The
report provides a comprehensive forecast of key segments
below-
Segmentation Overview
- Product
- 1.1 Heart valve replacement devices
- 1.2 Heart valve repair devices
- Geography
- 2.1 North America
- 2.2 Europe
- 2.3 Asia
- 2.4 Rest of World (ROW)
Get a glance at the market contribution of rest of the segments
- Download a FREE Sample Report in minutes!
1.1 Fastest growing segment:
Heart valve replacement devices are essential medical solutions
for individuals with damaged heart valves. These devices are
categorized into three types based on the valve material:
mechanical, tissue/bioprosthetic, and transcatheter. Mechanical
valves, manufactured from synthetic materials like plastic, carbon,
or metal, offer durability and longevity, typically lasting about
25 years. They are suitable for patients below 65 years with valve
stenosis or regurgitation and a history of atrial fibrillation.
However, patients must take anticoagulants for life due to the risk
of blood clots. Mechanical valves are ideal for patients with
small-sized hearts and are represented by products like Medtronic
Open Pivot Mechanical Heart Valves, Edwards INTUITY Elite valve
system, and Carbomedics Aortic Family. Tissue/bioprosthetic valves,
derived from animal tissues or human donor tissue, provide strength
and a ten-year lifespan without anticoagulant consumption. They are
recommended for older patients above 65 years. However, they may
not be suitable for neonatal and pediatric patients due to their
tendency to break down. Some popular bioprosthetic valves include
Medtronic's Mosaic and Mosaic Ultra Bioprostheses and Abbott's The
EPIC MITRAL STENDED TISSUE VALVE WITH LINX ANTICALCIFICATION
technology. Transcatheter heart valves, designed to replace the
aortic valve, are minimally invasive, requiring mild sedation and
few incisions, with short hospital stays. They are beneficial for
patients with aortic valve stenosis, improving their survival rate.
Complications associated with transcatheter valves include
bleeding, stroke, arrhythmias, kidney disease, infections, and
heart attack. Boston Scientific Corporation's LOTUS Edge Aortic
Valve System, JenaValve Technology's JenaValve Pericardial TAVR
System, and Medtronic's Evolut PRO System are some transcatheter
heart valves available in the market. The growth of the heart valve
repair and replacement devices market is driven by the increasing
prevalence of heart valve diseases, technological advancements, and
an aging population. The demand for minimally invasive procedures
and the rising awareness of heart valve replacement therapies are
also contributing factors. These trends are expected to propel the
growth of this market during the forecast period.
Analyst Review
Heart valves are essential components of the cardiovascular
system, allowing the efficient flow of blood between heart chambers
and the rest of the body. Damage to heart valves due to congenital
defects, acquired conditions such as infections, age-related
changes, heart attacks, or calcific degeneration can lead to
regurgitation or stenosis, requiring treatment. Heart disease
patients may first attempt medicines or lifestyle changes, but when
these methods fail, heart valve repair or replacement becomes
necessary. Transcatheter Aortic Valve Replacement (TAVR) and
Transcatheter Mitral Valve Replacement (TMVR) are minimally
invasive procedures that have gained popularity due to their lower
risk compared to open-heart surgery. The FDA has approved several
heart valve repair and replacement devices, leading to numerous
acquisitions and innovations in the market. Cardiovascular
diseases, including heart valve damage, affect millions worldwide,
driving the demand for these devices. However, their high cost and
stringent regulatory procedures can limit access to some patients.
Diagnostic technologies, such as echocardiography, help identify
heart valve issues early, allowing for timely intervention. Heart
valve repair and replacement devices are crucial for treating
various heart conditions, improving patients' quality of life and
longevity. The market for these devices is constantly evolving,
with ongoing research and development to address the unique needs
of different patient populations.
Market Overview
Heart valves are essential components of the cardiovascular
system, allowing the proper flow of blood through the heart. Damage
to heart valves can occur due to congenital defects, age-related
changes, infections, heart attacks, calcific degeneration, and
other heart diseases. Damaged valves can lead to conditions such as
regurgitation or stenosis, which can result in heart failure,
stroke, blood clots, and even death. Treatment options include
medicines, lifestyle changes, and surgical procedures. Heart valve
repair and replacement devices are used to address damaged or
diseased valves. These devices include prosthetic valves, such as
mechanical and biological valves, as well as transcatheter valves
like TAVR and TAVI. The industry has seen significant growth due to
the increasing prevalence of cardiovascular diseases and the aging
population. However, high costs and regulatory procedures,
including FDA approval and stringency, can hinder market growth.
Heart valve repair and replacement devices are used for both
surgical procedures and minimally invasive percutaneous procedures.
Mechanical valves and tissue bioprosthetic valves are common types
of surgical heart valves, while transcatheter heart valves and
percutaneous heart valves are used for minimally invasive
procedures. Industry growth drivers include the increasing number
of diagnostic technologies for congenital heart defects and the
development of new technologies like TMVR.
To understand more about this market- Download a FREE
Sample Report in minutes!
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Venodr Landscape
11 Vendor Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/heart-valve-repair-and-replacement-devices-market-size-to-increase-by-usd-2-58-billion-between-2023-to-2028--market-segmentation-by-product-geography-technavio-302331390.html
SOURCE Technavio
